These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 17880950
1. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization. Koundouros SN. Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950 [Abstract] [Full Text] [Related]
2. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ. BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [Abstract] [Full Text] [Related]
4. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Cha KY, Chung HM, Lee DR, Kwon H, Chung MK, Park LS, Choi DH, Yoon TK. Fertil Steril; 2005 May; 83(5):1461-5. PubMed ID: 15866585 [Abstract] [Full Text] [Related]
5. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM. Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479 [Abstract] [Full Text] [Related]
6. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK. Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177 [Abstract] [Full Text] [Related]
7. Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor. Nejad ES, Saedi T, Saedi S, Rashidi BH, Nekoo ZA, Jahangiri N. Gynecol Endocrinol; 2011 Feb; 27(2):117-20. PubMed ID: 20636232 [Abstract] [Full Text] [Related]
8. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization]. Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, Gao TM, Xing FQ. Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490 [Abstract] [Full Text] [Related]
11. Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome. Kim CH, Jeon GH, Kim SR, Kim SH, Chae HD, Kang BM. Fertil Steril; 2010 Jun; 94(1):236-41. PubMed ID: 19324344 [Abstract] [Full Text] [Related]
13. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032 [Abstract] [Full Text] [Related]
17. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W. Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398 [Abstract] [Full Text] [Related]
18. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study. Lavery SA, El-Shawarby SA, Turner C, Trew G. Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182 [Abstract] [Full Text] [Related]